Article metrics

Download PDFPDF

Protocol
A randomised, controlled, double blind study to assess mechanistic effects of combination therapy of dapagliflozin with exenatide QW versus dapagliflozin alone in obese patients with type 2 diabetes mellitus (RESILIENT): study protocol

 

Online download statistics by month:

Online download statistics by month: July 2021 to July 2021

AbstractFullPdf
Jul 2021453458121
Total453458121